About TransPacific Venture Capital Partners

From biopharmaceuticals to medical devices and digital healthcare services, TransPacific VC Partners is scouting the Pacific Rim for innovations that will help ensure humanity lives healthier, longer and more productive lives.

TransPacific has developed deep domain expertise and insight into the biopharmaceutical and biomedical industry. We channel that knowledge into every technology and healthcare investment we make - across the Pacific Rim.

The global healthcare industry sits at the intersection of several powerful long-term growth trends led by global demographics and the ineluctable advance of scientific innovation in treating disease.

We apply our experience in building great companies to meet the growing need for improved healthcare products and services, resulting in breakthrough therapies and technologies that have transformed the healthcare industry.

Our portfolio includes a selected number of biopharma and medical technology companies. We also invest in a number of pre-IPO or emerging high growth public companies on NASDAQ, New York Stock Exchange and Hong Kong Stock Exchange.

Biopharmaceutical

We invest in promising companies across the biopharmaceutical spectrum, at all clinical stages of development. We focus on novel therapeutics in major disease areas with unmet needs, such as immunotherapy oncology , neurosciences.

Medical Devices

We pursue investments across a broad range of all clinical stages of development, preferably near pre-marketing approval, while eyeing potential new markets created by new and disruptive medical technological advancements.

Artificial Intelligence in Healthcare

In the rapidly changing landscape of today’s U.S. healthcare delivery system, one thing that remains the same is our commitment to its healthcare services practice, which has evolved into a new platform based utilizing the state-of-the-art artificial intelligence.


For further information, please contact us online at Contact Form. Thank you.